The Retatrutide starting dose of 2 mg per week applies broadly across its uses
However, the underutilization of GLP-1 RAs represents a significant opportunity to improve post-transplant outcomes in this high-risk population
We encourage you to schedule an appointment if: Your period is delayed by more than 90 days (three months) You miss periods frequently or have irregular cycles You experience severe pain, abnormal bleeding, or other symptoms of hormonal imbalance While a mild delay in your period is often nothing to worry about, persistent or significant changes in your menstrual cycle should be evaluated
Collaborative decision-making between patients, endocrinologists or primary care providers, and ophthalmologists ensures that GLP-1 therapy is implemented safely with appropriate safeguards for ocular health
If uncertainty exists about appropriate placement, patients should consult their prescribing physician or a diabetes care and education specialist before proceeding with injections in unfamiliar areas
Eli Lillys dulaglutide (Trulicity) and semaglutide-adjacent GLP-1 competitive dynamics add further pressure
